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1. In the short-term, the main risks in the  
implementation of new technology in 
pharmacy are caused by technical 
problems. YES/NO? 
2. In the longer term, new technology 
improves the jobs of all pharmacy staff. 
YES/NO?
3. The main benefits of new technology in 
pharmacy are related to efficiency gains. 
YES/NO?
Questions to the audience
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 The pharmacy service redesign project:
 Making the Most of your Medicines (MMyM)
 Pharmacy Distribution Centre (PDC)
 Research aim and methodology
 Findings from first stage of the research
 Findings from second stage of the research
 Overall benefits gained
 Conclusions
Content of the presentation
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 ¼130m spend on Medicines 
(¼25m Homecare)
 Currently (March 2015) on 14 
different Hospital sites (includes 
specialist mental health)
 534 Pharmacy Staff 
(headcount)
 ¼20m Pharmacy Staff Cost
 153 wte Pharmacists
 198 wte Pharmacy Technicians
 78 wte Other Staff
NHS Greater Glasgow & Clyde
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Pharmacy service re-design
(2008 ± 2011)
The re-design vision:
 to redefine the core service around µSDWLHQWV
RZQPHGLFLQHV¶MMyM) medication 
management for hospital inpatients;
 to redesign, consolidate and automate hospital 
pharmacy medicines distribution, in order to 
release staff to near-patient tasks as part of 
integrated clinical teams;
 to adopt new technology as an integral part of 
this redesign. 
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Making the Most of Your Medicines 
(MMyM)
Principles:
 re-design of inpatient medication systems;
 drug administration as a care episode, not a 
task;
 XVHVSDWLHQWV¶own medicines and facilitates self-
administration by patients;
 reduces need for discharge prescriptions;
 care shared with community pharmacists;
 forms a vital link in the patient pack cycle in NHS 
Scotland.
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MMyM bedside locker
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Pharmacy Distribution Centre 
(PDC) from spring 2010
 Single facility responsible for the procurement and 
automated distribution of medicines to replenish 
ward and site pharmacy stocks for all hospitals 
and community clinics in the region.
 Eight robots (ROWA VMAX Extent2), with Prologs, 
working in tandem as an integrated storage and 
distribution system.
 Vmax picking head for accuracy and speed.
 Connected by conveyor systems.
 Interfaced with Ascribe Pharmacy Management system.
 Additional robot for safe handling of narcotic agents.
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Pharmacy Distribution Centre 
(PDC)
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 Most pharmacists, many pharmacy technicians and 
some pharmacy support staff were relocated to 
µQHDUHUWKHSDWLHQW¶ZDUG-based activities.
 Other pharmacy technicians and many members of 
support staff were redeployed to the PDC to 
manage the automated distribution processes.
 A minority of pharmacy staff were retained to 
deliver the remaining support services provided by 
hospital dispensaries. 
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Impact on work organisation
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Pharmacy service re-design,
NHS Greater Glasgow & Clyde
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PDC
 PDC 
investment = 
¼1.25m
 IT upgrade = 
¼0.9m
 Automated 
dispensaries = 
¼1.1m
 Staff training
 Total CAPEX 
over 3 years 
(2008±2011) = 
¼3.5m
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Research aim
 To analyse and assess the impact of the large-
scale automation of medicines distribution ± in 
both the initial stage of implementation and the 
longer term ± on efficiency and safety in the supply 
network as well as staff satisfaction. 
 The analysis is primarily set within a socio-
technical systems framework, as this enables due 
attention to be paid to both the technical and the 
social dimensions of a technological innovation, as 
well as the interactions between these dimensions.
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Findings from the academic 
and professional literature 
 Most of the attention so far has focused on 
relatively small-scale dispensing systems rather 
than large-scale distribution systems (Goundrey-
Smith 2013).
 The severity of implementation problems is likely to 
increase disproportionately with the scale and 
complexity of a healthcare technology installation 
(Greenhalgh & Stones 2010).
 There are still important questions about the nature 
of interactions within a network of human actors 
and technological entities (such as IT systems or 
robots) in the longer term (Cresswell et al. 2010).
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Research methodology
1. First stage of the research (2010 ± 2011):
 Action research: monthly project board meetings 
comprising senior pharmacy management, key 
pharmacy staff and university research team.
 Interviews with thirty-six pharmacy staff from four 
hospital sites (700-900 inpatient beds per site) in the 
summer of 2010. 
2. Second stage of the research (2012 ± 2013):
 Interviews with another thirty-six pharmacy staff in the 
second half of 2012.
 µ.H\VWDNHKROGHU¶LQWHUYLHZVwith management, 
employee partnership groups and trade unions.  
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 Three problem areas related to the technical 
dimensions of the newly redesigned system:
1. the robotic storage and distribution system;
2. the pharmacy management system;
3. sourcing medicines unavailable from the pharmacy 
distribution centre.
 The other three problem areas related to its social 
or human dimensions:
1. understanding staff roles within the new system;
2. the importance of effective communication;
3. the effect of the redesign on staff morale. 
18
Findings from the first stage 
of the research
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Discussion of findings from 
the first stage (1)
 Previous (legacy) design configuration of the storage 
and distribution system: decentralised in nature, in 
terms of both its technical and social dimensions.
 New configuration: technical dimension (large-scale 
robotic system in a separate location) strongly 
centralised, but social dimension (responsibility for 
the dispensing of medicines to individual hospital 
patients) still decentralised.
 Staff perception: centralised characteristics of the 
technical dimension no longer in step with 
decentralised characteristics of the social dimension. 
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 Two-way negative interaction between the 
technical dimension of the new system and its 
social dimension.
 Negative impact of technical problems on the ability of 
local teams to provide an effective pharmacy service.
 In response, local teams WRRNµGHIHQVLYH¶action ±
thereby exacerbating technical problems even further.
 The implementation of a large and technically 
complex system is likely to result in unintended 
consequences that are almost impossible to 
specify beforehand.
20
Discussion of findings from 
the first stage (2)
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Benefits gained by 2011 
 Early implementation problems, particularly those 
of technical nature, had been overcome by a 
combination of efforts directed from the centre and 
local learning.
 Reported benefits of redesign programme:
 Release of floor space.
 More effective use of pharmacy staff.
 Patient safety improvements.
 Stock rationalisation and order-processing efficiencies.
 Pharmacy stock waste reduction.
 Processing and administration enhancements.
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 Mixed impact of the redesign project on 
training opportunities for staff.
 Different experiences between front-stage 
staff and back-stage staff.
 More job satisfaction and control over their work 
for pharmacy technicians and support workers 
involved ward-based services. 
 Less opportunities for progression for pharmacy 
technicians redeployed in a back-stage capacity 
to the PDC.
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Findings from the second 
stage of the research
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 Three recurring themes:
1. Limited opportunity for staff engagement in 
shaping the initial decision-making process.
2. Post-redesign opportunities for personal 
development differed between pharmacy staff 
groups.
3. Positive impact on job quality for staff delivering 
front-stage services µQHDUHUWRSDWLHQWV¶PRUH
negative impact for staff redeployed to perform 
back-stage standardised tasks.
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Discussion of findings from 
the second stage
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Overall benefits gained (2015)
PDC 
 PDC operating 24 hours/day, 7 days/week
 Weekend support for ward based teams.
 Out-of-hours emergency supply on video call remote 
authorisation of pharmacist.
 Current PDC dashboard performance:
 Service level: 98.1%
 Stock value held: ¼5.3m
 Days stock: less than 8 days
 Orders picked per week: 24,000 (90,000 packs)
 Automated picks: 78% of packs
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Overall benefits gained (2015)
MMyM (1)
 Access to MMyM service
 January 2015: 96% of inpatient beds (36% in 2008).
 Access to Clinical Pharmacist
 June 2014: 96% of hospital inpatients (60% in 2007).
 Improved patient safety through MMyM
 MMyM assists medicines reconciliation and 
highlights any patient non-compliance.
 Nursing staff report improved patient safety.
 Improves communication of information at inpatient 
discharge to community pharmacists.
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Overall benefits gained (2015)
MMyM (2)
 MMyM quality and efficiency
 Compliance with requirement to include patient 
information leaflet with each dispensed item.
 High level of patient satisfaction.
 ¼8.50 saved per patient admitted through avoidance 
RIQHHGOHVVGHVWUXFWLRQRISDWLHQW¶VPHGLFLQHV
brought with them in to hospital.
 Avoidance of duplicate stock ordering: ¼400 per bed 
per annum.
 Dispensing time for discharge reduced from 7 
minutes per item to 3 minutes.
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Conclusions
 New technology may lead to unintended first-order 
consequences, but can also generate potentially 
serious adverse feedback loops between the social 
and technical dimensions of the new system. 
 The longer-term impact of new technology may be 
quite different for different groups of healthcare staff. 
Frontline staff are freed from more routine administra-
tive activities, enabling them to spend more time 
directly with patients.
 If early-stage problems can be effectively overcome, 
then significant benefits are achievable in terms of 
patient safety, quality and efficiency.
27
Dr Robert van der Meer, EAHP 2015
1. In the short-term, the main risks in the  
implementation of new technology in 
pharmacy are caused by technical 
problems.
 NO. Problems may occur in both the 
technical and the social dimensions of the 
new system. Of particular concern is the 
possibility of adverse feedback loops 
between the different dimensions of the 
system.
Questions to the audience -
reprise
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2. In the longer term, new technology 
improves the jobs of all pharmacy staff.
 NO. Pharmacy staff moved to back-stage 
activities (to manage automated processes 
away from patients) may experience a 
deterioration in job quality. Sufficient 
opportunities for progression should be 
created for staff in that position.
Questions to the audience -
reprise
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3. The main benefits of new technology in 
pharmacy are related to efficiency gains.
 NO. New technology can free up key 
resources and enable pharmacy staff to 
focus on near-patient tasks ± thereby 
improving patient safety and service quality 
as well as efficiency. But for new technology 
to be successful, it must be effectively 
integrated into the socio-technical system.
Questions to the audience -
reprise
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